Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk G Dechering

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Pharmacology & Physiology|May 31, 2017
Antiarrhythmic properties of ivabradine in an experimental model of Short-QT- SyndromeGerrit Frommeyer, Jan Weller, Christian Ellermann, et al.
Cardiovascular Toxicology|September 22, 2018
Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT SyndromeGerrit Frommeyer, Jan Weller, Christian Ellermann, et al.
International Journal of Cardiology|March 7, 2017
Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?Gerrit Frommeyer, Magdalena Sterneberg, Dirk G Dechering, et al.
European Journal of Internal Medicine|December 7, 2019
Prospective blinded Evaluation of the smartphone-based AliveCor Kardia ECG monitor for Atrial Fibrillation detection: The PEAK-AF studyFelix K Wegner, Simon Kochhäuser, Christian Ellermann, et al.
Journal of Cardiovascular Electrophysiology|June 11, 2016
Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT SyndromeGerrit Frommeyer, Christian Ellermann, Dirk G Dechering, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 11, 2017
Broad antiarrhythmic effect of mexiletine in different arrhythmia modelsGerrit Frommeyer, Jonas Garthmann, Christian Ellermann, et al.
Stroke|March 2, 2013
Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitorsMartin A Ritter, Simon Kochhäuser, Thomas Duning, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 6, 2016
Antiarrhythmic effect of vernakalant in an experimental model of Long-QT-syndromeGerrit Frommeyer, Catharina Clauss, Christian Ellermann, et al.
Basic & Clinical Pharmacology & Toxicology|June 20, 2017
Ivabradine Reduces Digitalis-induced Ventricular ArrhythmiasGerrit Frommeyer, Jan Weller, Christian Ellermann, et al.
International Journal of Cardiology|April 2, 2013
Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repairKristina Wasmer, Julia Köbe, Dirk G Dechering, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Pharmacology & Physiology|May 31, 2017
Antiarrhythmic properties of ivabradine in an experimental model of Short-QT- SyndromeGerrit Frommeyer, Jan Weller, Christian Ellermann, et al.
Cardiovascular Toxicology|September 22, 2018
Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT SyndromeGerrit Frommeyer, Jan Weller, Christian Ellermann, et al.
International Journal of Cardiology|March 7, 2017
Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?Gerrit Frommeyer, Magdalena Sterneberg, Dirk G Dechering, et al.
European Journal of Internal Medicine|December 7, 2019
Prospective blinded Evaluation of the smartphone-based AliveCor Kardia ECG monitor for Atrial Fibrillation detection: The PEAK-AF studyFelix K Wegner, Simon Kochhäuser, Christian Ellermann, et al.
Journal of Cardiovascular Electrophysiology|June 11, 2016
Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT SyndromeGerrit Frommeyer, Christian Ellermann, Dirk G Dechering, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 11, 2017
Broad antiarrhythmic effect of mexiletine in different arrhythmia modelsGerrit Frommeyer, Jonas Garthmann, Christian Ellermann, et al.
Stroke|March 2, 2013
Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitorsMartin A Ritter, Simon Kochhäuser, Thomas Duning, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 6, 2016
Antiarrhythmic effect of vernakalant in an experimental model of Long-QT-syndromeGerrit Frommeyer, Catharina Clauss, Christian Ellermann, et al.
Basic & Clinical Pharmacology & Toxicology|June 20, 2017
Ivabradine Reduces Digitalis-induced Ventricular ArrhythmiasGerrit Frommeyer, Jan Weller, Christian Ellermann, et al.
International Journal of Cardiology|April 2, 2013
Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repairKristina Wasmer, Julia Köbe, Dirk G Dechering, et al.
Pageof 8